{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:24:17Z","timestamp":1787160257769,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T00:00:00Z","timestamp":1376438400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a promising treatment option for selected patients with peritoneal carcinomatosis. This retrospective study investigated the relationship between baseline nutritional assessment with subsequent parenteral nutritional (PN) and clinical outcomes in cancer patients undergoing CRS and HIPEC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A consecutive series of 60 patients undergoing CRS and HIPEC at our institution between January 2009 and May 2011. Subjective Global Assessment (SGA) was used to assess nutritional status. Patients were classified preoperatively as: well nourished (SGA-A), mildly-moderately malnourished (SGA-B), and severely malnourished (SGA-C). For PN, patients were divided into 2 groups: those who received PN (PN+) and those who did not receive PN (PN-). The primary outcomes of interest were length of stay (LOS), postoperative complications, ECOG performance status (PS) and survival. LOS was calculated as the number of days in the hospital post surgery. Performance status was measured on a scale of 0-4. Survival was calculated from the date of first visit to the date of death\/last contact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 60 patients, 19 were males and 41 females. The mean age at presentation was 50.3 years. The most common cancer types were colorectal (n\u2009=\u200924) and gynecologic (n\u2009=\u200919) with the majority of patients (n\u2009=\u200947) treated previously before coming to our institution. 33 patients were SGA-A, 22 SGA-B and 5 SGA-C prior to surgery. Of a total of 60 patients, 31 received PN. Mean LOS for the entire cohort was 16.2 days (SD\u2009=\u20099.8). Mean LOS for preoperative SGA-A, SGA-B and SGA-C were 15.0, 15.2 and 27.8 days respectively (ANOVA p\u2009=\u20090.02). Overall incidence of complications was 26.7% (16\/60). Complications were recorded in 9 of 33 (27.3%) preoperative SGA-A patients and 7 of 27 (25.9%) SGA-B\u2009+\u2009C patients (p\u2009=\u20090.91). The median overall survival was 17.5 months (95% CI\u2009=\u200913.0 to 22.1 months). Median survival for preoperative SGA-A and SGA-B\u2009+\u2009C cohorts was 22.4 and 10.4 months respectively (p\u2009=\u20090.006).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The preoperative SGA predicts LOS and survival in cancer patients undergoing HIPEC. Future randomized clinical trials in this patient population should investigate the systematic provision of PN to all malnourished patients in the preoperative period for a minimum of 7-10 days with the continuation of PN in the postoperative period.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1475-2891-12-118","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T20:23:25Z","timestamp":1376425405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy"],"prefix":"10.1186","volume":"12","author":[{"given":"Pankaj G","family":"Vashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Digant","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn A","family":"Lammersfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenten","family":"Popiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhasis","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komen C","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,14]]},"reference":[{"key":"693_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1477-7819-7-5","volume":"7","author":"G Glockzin","year":"2009","unstructured":"Glockzin G, Schlitt HJ, Piso P: Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009, 7: 5-10.1186\/1477-7819-7-5. 5","journal-title":"World J Surg Oncol"},{"key":"693_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejso.2010.11.004","volume":"37","author":"M Deraco","year":"2011","unstructured":"Deraco M, Baratti D, Laterza B, Balestra MR, Mingrone E, Macri A, et al: Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer. Eur J Surg Oncol. 2011, 37: 4-9. 10.1016\/j.ejso.2010.11.004.","journal-title":"Eur J Surg Oncol"},{"key":"693_CR3","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, et al: Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010, 17: 2370-2377. 10.1245\/s10434-010-1039-7.","journal-title":"Ann Surg Oncol"},{"key":"693_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.ejso.2008.10.006","volume":"35","author":"J Hagendoorn","year":"2009","unstructured":"Hagendoorn J, van Lammeren G, Boerma D, van der BE, Wiezer MJ, van Ramshorst B: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival. Eur J Surg Oncol. 2009, 35: 833-837. 10.1016\/j.ejso.2008.10.006.","journal-title":"Eur J Surg Oncol"},{"key":"693_CR5","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.ejso.2009.03.004","volume":"35","author":"MJ Pavlov","year":"2009","unstructured":"Pavlov MJ, Kovacevic PA, Ceranic MS, Stamenkovic AB, Ivanovic AM, Kecmanovic DM: Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer \u2013 12-year single center experience. Eur J Surg Oncol. 2009, 35: 1186-1191. 10.1016\/j.ejso.2009.03.004.","journal-title":"Eur J Surg Oncol"},{"key":"693_CR6","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003, 21: 3737-3743. 10.1200\/JCO.2003.04.187.","journal-title":"J Clin Oncol"},{"key":"693_CR7","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H: 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008, 15: 2426-2432. 10.1245\/s10434-008-9966-2.","journal-title":"Ann Surg Oncol"},{"key":"693_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/PPO.0b013e3181a58d56","volume":"15","author":"F Mohamed","year":"2009","unstructured":"Mohamed F, Moran BJ: Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Canc J. 2009, 15: 196-199. 10.1097\/PPO.0b013e3181a58d56.","journal-title":"Canc J"},{"key":"693_CR9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","volume":"249","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Saxena A, Morris DL: Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg. 2009, 249: 900-907. 10.1097\/SLA.0b013e3181a45d86.","journal-title":"Ann Surg"},{"key":"693_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/jso.21050","volume":"98","author":"R McQuellon","year":"2008","unstructured":"McQuellon R, Gavazzi C, Piso P, Swain D, Levine E: Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care. J Surg Oncol. 2008, 98: 300-305. 10.1002\/jso.21050.","journal-title":"J Surg Oncol"},{"key":"693_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1053\/ejso.2000.1033","volume":"27","author":"RP McQuellon","year":"2001","unstructured":"McQuellon RP, Loggie BW, Fleming RA, Russell GB, Lehman AB, Rambo TD: Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol. 2001, 27: 65-73. 10.1053\/ejso.2000.1033.","journal-title":"Eur J Surg Oncol"},{"key":"693_CR12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.ejcn.1602540","volume":"61","author":"B Laky","year":"2007","unstructured":"Laky B, Janda M, Bauer J, Vavra C, Cleghorn G, Obermair A: Malnutrition among gynaecological cancer patients. Eur J Clin Nutr. 2007, 61: 642-646.","journal-title":"Eur J Clin Nutr"},{"key":"693_CR13","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jclinepi.2005.08.020","volume":"59","author":"D Gupta","year":"2006","unstructured":"Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG, Lammersfeld CA: Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol. 2006, 59: 704-709. 10.1016\/j.jclinepi.2005.08.020.","journal-title":"J Clin Epidemiol"},{"key":"693_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.ejcn.1602029","volume":"59","author":"D Gupta","year":"2005","unstructured":"Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF: Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr. 2005, 59: 35-40. 10.1038\/sj.ejcn.1602029.","journal-title":"Eur J Clin Nutr"},{"key":"693_CR15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/ajcn\/80.6.1634","volume":"80","author":"D Gupta","year":"2004","unstructured":"Gupta D, Lammersfeld CA, Burrows JL, Dahlk SL, Vashi PG, Grutsch JF, et al: Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr. 2004, 80: 1634-1638.","journal-title":"Am J Clin Nutr"},{"key":"693_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/1471-2407-10-232","volume":"10","author":"B Laky","year":"2010","unstructured":"Laky B, Janda M, Kondalsamy-Chennakesavan S, Cleghorn G, Obermair A: Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study. BMC Canc. 2010, 10: 232-10.1186\/1471-2407-10-232. 232","journal-title":"BMC Canc"},{"key":"693_CR17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.nut.2007.06.005","volume":"23","author":"T Wakahara","year":"2007","unstructured":"Wakahara T, Shiraki M, Murase K, Fukushima H, Matsuura K, Fukao A, et al: Nutritional screening with Subjective Global Assessment predicts hospital stay in patients with digestive diseases. Nutrition. 2007, 23: 634-639. 10.1016\/j.nut.2007.06.005.","journal-title":"Nutrition"},{"key":"693_CR18","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1111\/j.1572-0241.2007.01437.x","volume":"102","author":"F Di Fiore","year":"2007","unstructured":"Di Fiore F, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, et al: Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol. 2007, 102: 2557-2563. 10.1111\/j.1572-0241.2007.01437.x.","journal-title":"Am J Gastroenterol"},{"key":"693_CR19","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3748\/wjg.v17.i13.1779","volume":"17","author":"Y Chen","year":"2011","unstructured":"Chen Y, Liu BL, Shang B, Chen AS, Liu SQ, Sun W, et al: Nutrition support in surgical patients with colorectal cancer. World J Gastroenterol. 2011, 17: 1779-1786. 10.3748\/wjg.v17.i13.1779.","journal-title":"World J Gastroenterol"},{"key":"693_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-7800-2-3","volume":"2","author":"RL Harmon","year":"2005","unstructured":"Harmon RL, Sugarbaker PH: Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol. 2005, 2: 3-10.1186\/1477-7800-2-3.","journal-title":"Int Semin Surg Oncol"},{"key":"693_CR21","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.3747\/co.v18i2.663","volume":"18","author":"F Mohamed","year":"2011","unstructured":"Mohamed F, Cecil T, Moran B, Sugarbaker P: A new standard of care for the management of peritoneal surface malignancy. Curr Oncol. 2011, 18: e84-e96.","journal-title":"Curr Oncol"},{"key":"693_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/014860718701100108","volume":"11","author":"AS Detsky","year":"1987","unstructured":"Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, et al: What is subjective global assessment of nutritional status?. JPEN J Parenter Enteral Nutr. 1987, 11: 8-13. 10.1177\/014860718701100108.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"693_CR23","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S0899-9007(00)00398-1","volume":"16","author":"DR Duerksen","year":"2000","unstructured":"Duerksen DR, Yeo TA, Siemens JL, O'Connor MP: The validity and reproducibility of clinical assessment of nutritional status in the elderly. Nutrition. 2000, 16: 740-744. 10.1016\/S0899-9007(00)00398-1.","journal-title":"Nutrition"},{"key":"693_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1471-6712.1996.tb00330.x","volume":"10","author":"AC Ek","year":"1996","unstructured":"Ek AC, Unosson M, Larsson J, Ganowiak W, Bjurulf P: Interrater variability and validity in subjective nutritional assessment of elderly patients. Scand J Caring Sci. 1996, 10: 163-168. 10.1111\/j.1471-6712.1996.tb00330.x.","journal-title":"Scand J Caring Sci"},{"key":"693_CR25","first-page":"1094","volume":"8","author":"G Enia","year":"1993","unstructured":"Enia G, Sicuso C, Alati G, Zoccali C: Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant. 1993, 8: 1094-1098.","journal-title":"Nephrol Dial Transplant"},{"key":"693_CR26","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1080\/07315724.2000.10718954","volume":"19","author":"GS Sacks","year":"2000","unstructured":"Sacks GS, Dearman K, Replogle WH, Cora VL, Meeks M, Canada T: Use of subjective global assessment to identify nutrition-associated complications and death in geriatric long-term care facility residents. J Am Coll Nutr. 2000, 19: 570-577. 10.1080\/07315724.2000.10718954.","journal-title":"J Am Coll Nutr"},{"key":"693_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1191\/0269216302pm486oa","volume":"16","author":"L Thoresen","year":"2002","unstructured":"Thoresen L, Fjeldstad I, Krogstad K, Kaasa S, Falkmer UG: Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med. 2002, 16: 33-42. 10.1191\/0269216302pm486oa.","journal-title":"Palliat Med"},{"key":"693_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1046\/j.1440-1673.1999.433665.x","volume":"43","author":"ML Ferguson","year":"1999","unstructured":"Ferguson ML, Bauer J, Gallagher B, Capra S, Christie DR, Mason BR: Validation of a malnutrition screening tool for patients receiving radiotherapy. Australas Radiol. 1999, 43: 325-327. 10.1046\/j.1440-1673.1999.433665.x.","journal-title":"Australas Radiol"},{"key":"693_CR29","first-page":"339","volume":"9","author":"J Hasse","year":"1993","unstructured":"Hasse J, Strong S, Gorman MA, Liepa G: Subjective global assessment: alternative nutrition-assessment technique for liver-transplant candidates. Nutrition. 1993, 9: 339-343.","journal-title":"Nutrition"},{"key":"693_CR30","first-page":"35","volume":"7","author":"S Hirsch","year":"1991","unstructured":"Hirsch S, de Obaldia N, Petermann M, Rojo P, Barrientos C, Iturriaga H, et al: Subjective global assessment of nutritional status: further validation. Nutrition. 1991, 7: 35-37.","journal-title":"Nutrition"},{"key":"693_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0261-5614(99)80054-5","volume":"18","author":"C Persson","year":"1999","unstructured":"Persson C, Sjoden PO, Glimelius B: The Swedish version of the patient-generated subjective global assessment of nutritional status: gastrointestinal vs urological cancers. Clin Nutr. 1999, 18: 71-77. 10.1016\/S0261-5614(99)80054-5.","journal-title":"Clin Nutr"},{"key":"693_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/0884533608314530","volume":"23","author":"MB Huhmann","year":"2008","unstructured":"Huhmann MB, August DA: Review of American Society for Parenteral and Enteral Nutrition (ASPEN) Clinical Guidelines for Nutrition Support in Cancer Patients: nutrition screening and assessment. Nutr Clin Pract. 2008, 23: 182-188. 10.1177\/0884533608314530.","journal-title":"Nutr Clin Pract"},{"key":"693_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejso.2004.09.011","volume":"31","author":"U Schmidt","year":"2005","unstructured":"Schmidt U, Dahlke MH, Klempnauer J, Schlitt HJ, Piso P: Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2005, 31: 53-58. 10.1016\/j.ejso.2004.09.011.","journal-title":"Eur J Surg Oncol"},{"key":"693_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000332914","volume":"59","author":"D Gupta","year":"2011","unstructured":"Gupta D, Vashi PG, Lammersfeld CA, Braun DP: Role of nutritional status in predicting the length of stay in cancer: a systematic review of the epidemiological literature. Ann Nutr Metab. 2011, 59: 96-106. 10.1159\/000332914.","journal-title":"Ann Nutr Metab"},{"key":"693_CR35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/01.ccx.0000235204.54579.14","volume":"12","author":"RG Martindale","year":"2006","unstructured":"Martindale RG, Maerz LL: Management of perioperative nutrition support. Curr Opin Crit Care. 2006, 12: 290-294. 10.1097\/01.ccx.0000235204.54579.14.","journal-title":"Curr Opin Crit Care"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-12-118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2891-12-118\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-12-118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-12-118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:00:29Z","timestamp":1630530029000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/1475-2891-12-118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,14]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["693"],"URL":"https:\/\/doi.org\/10.1186\/1475-2891-12-118","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,14]]},"assertion":[{"value":"10 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"118"}}